Lifetime impact of achondroplasia study in Europe

Lifetime impact of achondroplasia study in Europe (LIAISE) - PubMed

The findings of this study suggest that, across an individual's lifetime, achondroplasia is associated with multisystem complications, ...

Lifetime impact of achondroplasia study in Europe (LIAISE)

The mean percentage of impairment while working due to achondroplasia (impact on productivity over the past week) was 15.4% (23.3%) and the mean ...

Lifetime impact of achondroplasia study in Europe (LIAISE)

Achondroplasia is the most common skeletal dysplasia, with an estimated prevalence of approximately 1:22,000 live births and over 250,000 people ...

Lifetime Impact of Achondroplasia Study in Europe - LIAISE

Lifetime Impact of Achondroplasia Study in Europe - LIAISE · Open to 300 participants ages 5 to 70 years · Caregivers may complete the questionnaire if the ...

Review Article Lifetime impact of achondroplasia: Current evidence ...

In addition, a recently published study assessing mental health in adults with skeletal dysplasia (57% with achondroplasia) found a substantial number of ...

Lifetime impact of achondroplasia study in Europe (LIAISE)

Title: Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. ; Language: English ; Authors: Maghnie, ...

(PDF) Lifetime impact of achondroplasia study in Europe (LIAISE)

Conclusions This study indicates that the care and follow up of adults with achondroplasia is challenging. Individuals are often lost to, or decline, follow up ...

Lifetime Impact Study for Achondroplasia (LISA): Findings from an ...

Overall, the Lifetime Impact Study for Achondroplasia study provides extensive data on health-related quality of life, psychosocial impact, and health care ...

Lifetime impact of achondroplasia in Europe (LIAISE) - ResearchGate

Lifetime impact of achondroplasia in Europe (LIAISE): findings from a multinational observational study ... To read the full-text of this research ...

Lifetime impact of achondroplasia study in Europe (LIAISE) - Pure

Patient height correlated with multiple patient-reported outcomes. Conclusions: The findings of this study suggest that, across an individual's lifetime, ...

Lifetime impact of achondroplasia: current evidence and ...

In a study of 114 patients with achondroplasia treated at a US skeletal dysplasia clinic, 47% of those imaged (38/83) were found to have foramen ...

Lifetime impact of achondroplasia: Current evidence and ...

Europe PMC is an archive of life sciences journal literature.

Achondroplasia Clinical Trials | BioMarin

... effects on patients with Achondroplasia in a real-world setting in Europe ... A Virtual Study in Achondroplasia ... Lifetime Impact Study for Achondroplasia (LISA) ...

Lifetime impact of achondroplasia study in Europe (LIAISE)

Achondroplasia 100% · Bone Dysplasia 12% · Fibroblast Growth Factor Receptor 3 12% · Lifespan 100% · Limb 37% · Medical Record 12% · Observational Study 100% · Patient ...

New treatments for children with achondroplasia - The Lancet

Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. Orphanet J Rare Dis. 2023; 18:56. Crossref.

European Achondroplasia Forum Practical Considerations for ...

... lifelong management. There ... Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study.

Persistent growth-promoting effects of vosoritide in children with ...

Mean treatment duration was 4 (0.78) years. At year 3, the largest mean (SD) changes were observed in the Quality of Life of Short Stature Youth physical score ...

Burden and Treatment of Achondroplasia: A Systematic Literature ...

50.30; p = 0.85) [45]. In two studies, caregiver emotional wellbeing was reportedly negatively impacted by achondroplasia [53, 54]. The impact ...

a modified Delphi study | Orphanet Journal of Rare Diseases

Lifetime impact of achondroplasia in Europe (LIAISE): findings from a multinational observational study. Mol Genet Metab. 2021;132S1:S65–6 ...

Current evidence and perspectives on the natural history - BridgeBio

[83] BioMarin Pharmaceutical, Lifetime Impact of Achondroplasia Study in Europe-. LIAISE (LIAISE). ... [84] BioMarin Pharmaceutical, Lifetime Impact Study for ...